GLI2 and neoplasm: Our data showed that the reduction in the GLI2 expression in vitro the B16F10/shTGF-β1 cells and in vivo tumor tissues may decrease the TGF-β1 target gene expression and may inhibit the pro-oncogenic activity downstream of the TGF-β signaling.